Adult ID

Pediatric ID

Investigative ID

Global ID

Epi/Infection Control

Oral Abstract

311 - Vaccination II - Other

Presentations:

• 3:15 PM - 3:30 PM

  2901 - Measles in the United States During the Postelimination Era, 2017-2019
  Paul Gastanaduy, MD, MPH – CDC; Adria D. Lee, MSPH – Centers for Disease Control and Prevention; Susan B. Redd, none – Division of Viral Diseases, Centers for Disease Control and Prevention; Nakia S. Clemmons, MPH – Centers for Disease Control and Prevention; Manisha Patel, MD MS – CDC
• 3:30 PM - 3:45 PM

  2902 - Pertussis Antibody Levels in Preterm Infants After Maternal Tdap Immunization During Pregnancy
  C. Mary Healy, MD – Baylor College of Medicine; Marcia Rench, BSN – Baylor College of Medicine; Laurie Swaim, MD – Baylor College of Medicine; Gowrisankar Rajam, PhD – Merck & Co., Inc.; Fiona Havers, MD, MHS – Centers for Disease Control and Prevention; Susan Hariri, PhD – Centers for Disease Control and Prevention; Jarad Schiffer, PhD – Centers for Disease Control and Prevention; Carol J. Baker, MD – University of Texas Health Science Center
• 3:45 PM - 4:00 PM

  2903 - Post PCV13 Dynamics of Non-Vaccine Serotype (NVT): Disproportionate Increase of the Additional PCV20 Candidate Serotypes in Respiratory and Invasive Disease in Young Children
  Shalom Ben-Shimol, MD – Soroka University Med Ctr and Ben-Gurion University; Noga Givon-Lavi, PhD – Soroka Univ Med Ctr and Ben-Gurion Univ; Leore Kotler, Medical Student 4th year – Soroka Univ Med Ctr and Ben-Gurion Univ; David Greenberg, MD – Soroka Univ Med Ctr and Ben-Gurion Univ; Ron Dagan, MD – Ben-Gurion University of the Negev
• 4:00 PM - 4:15 PM

  2904 - Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice
  Brett W. Jagger, MD, PhD – Washington University; Kimberly A. Dowd, PhD – National Institutes of Health; Rita Chen, B.S. – Washington University; Pritesh Desai, PhD – Washington University; Sunny Himansu, MBA, SM – Moderna, Inc.; Barney S. Graham, MD, PhD – National Institutes of Health; Theodore C. Pierson, PhD – National Institutes of Health; Michael S. Diamond, MD, PhD – Washington University
• 4:15 PM - 4:30 PM

  2905 - Long-term Immunological Persistence of the Adjuvanted Recombinant Zoster Vaccine: Clinical Data and Mathematical Modeling
  Adriana Bastidas, MD – GSK; Grégory Catteau, MSc – GSK; Stéphanie Volpe, MSc – GSK; Tomas Mrkvan, PhD – GSK; Adaora Enemuo, MSc – GSK; Jan Smetana, MD, PhD – Faculty of Military Health Sciences, University of Defense; Tino Schwarz, PhD – Klinikum Wuerzburg Mitte, Standort Juliusspital; Lars Rombo, MD, PhD – Dept of Infectious Diseases, Uppsala University; Karlis Pauksens, MD – Dept of Infectious Diseases, Uppsala University; Estelle Berengier, MSc – GSK; Caroline Hervé, PhD – GSK; Lidia Oostvogels, MD – GSK; Anne Schuind, MD – GSK

Co-Author(s)

• AB

  Adriana Bastidas, MD

  Senior Clinical Research and Development Lead
  GSK
  Wavre, Brabant Wallon, Belgium

  Disclosure: GSK group of companies: Employee, Shareholder
• GC

  Grégory Catteau, MSc

  Statistician
  GSK
  Rixensart, Brabant Wallon, Belgium

  Disclosure: GSK group of companies: Board Member
• KD

  Kimberly Dowd, PhD

  Associate Scientist
  National Institutes of Health
  Bethesda, MD

  Disclosure: NIH: Employee, K.A.D. is named as inventor on U.S. government-owned patent application(s) for ZIKV DNA vaccine technology.
• NG

  Noga Givon-Lavi, PhD

  Epidemiologist
  Soroka Univ Med Ctr and Ben-Gurion Univ
  Beer Sheva, HaDarom, Israel

  Disclosure: Nothing to disclose
• AL

  Adria Lee, MSPH

  Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• MR

  Marcia Rench, BSN

  Research Associate
  Baylor College of Medicine
  Houston, TX

  Disclosure: Nothing to disclose
• RC

  Rita Chen, B.S.

  MSTP Student
  Washington University
  St. Louis, MO

  Disclosure: Nothing to disclose
• LK

  Leore Kotler, Medical Student 4th year

  Medical Student
  Soroka Univ Med Ctr and Ben-Gurion Univ
  Beer Sheva, HaDarom, Israel

  Disclosure: Nothing to disclose
• SR

  Susan Redd, none

  Public Health Analyst
  Division of Viral Diseases, Centers for Disease Control and Prevention
  Lilburn, GA

  Disclosure: Nothing to disclose
• LS

  Laurie Swaim, MD

  Professor of Obstetrics and Gynecology
  Baylor College of Medicine
  Houston, TX

  Disclosure: Nothing to disclose
• SV

  Stéphanie Volpe, MSc

  MPH
  GSK
  Wavre, Brabant Wallon, Belgium

  Disclosure: GSK group of companies: Employee
• NC

  Nakia Clemmons, MPH

  Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• PD

  Pritesh Desai, PhD

  Postdoctoral Research Associate
  Washington University
  St. Louis, MO

  Disclosure: Nothing to disclose
• DG

  David Greenberg, MD

  Professor of Pediatrics and Infectious Disease
  Soroka Univ Med Ctr and Ben-Gurion Univ
  Beer Sheva, HaDarom, Israel

  Disclosure: Pfizer, MSD: Consultant, Grant/Research Support, Speaker's Bureau
• TM

  Tomas Mrkvan, PhD

  Clinical Research and Development Lead
  GSK
  Wavre, Brabant Wallon, Belgium

  Disclosure: GSK group of companies: Employee, Shareholder
• GR

  Gowrisankar Rajam, PhD

  Associate Principal Scientist
  Merck & Co., Inc.
  Collegeville, PA

  Disclosure: Nothing to disclose
• RD

  Ron Dagan, MD

  Professor of Pediatrics and Infectious Disease
  Ben-Gurion University of the Negev
  Beer Sheva, HaDarom, Israel

  Disclosure: Memed, MSD, Pfizer: Consultant, Grant/Research Support, Advisor or Review Panel member, Speaker's Bureau
• AE

  Adaora Enemuo, MSc

  Biostatistician
  GSK
  Rockville, MD

  Disclosure: Nothing to disclose
• FH

  Fiona Havers, MD, MHS

  Medical Officer
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• SH

  Sunny Himansu, MBA, SM

  Scientist
  Moderna, Inc.
  Cambridge, MA

  Disclosure: Moderna: Employee, S.H. is an employee of Moderna, Inc.
• 

  Manisha Patel, MD MS

  Team Lead, Domestic Measles
  CDC
  Atlanta, GA

  Disclosure: Nothing to disclose
• BG

  Barney Graham, MD, PhD

  Deputy Director
  National Institutes of Health
  Bethesda, MD

  Disclosure: NIH: Employee, B.S.G. is named as inventor on U.S. government-owned patent application(s) for ZIKV DNA vaccine technology.
• SH

  Susan Hariri, PhD

  Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• JS

  Jan Smetana, MD, PhD

  Assoc. Prof.
  Faculty of Military Health Sciences, University of Defense
  Hradec Kralove, Kralovehradecky kraj, Czech Republic

  Disclosure: GSK group of companies: Scientific Research Study Investigator
  Sanofi: Speaker's Bureau
• TP

  Theodore Pierson, PhD

  Chief
  National Institutes of Health
  Bethesda, MD

  Disclosure: NIH: Employee, T.C.P. is named as inventor on U.S. government-owned patent application(s) for ZIKV DNA vaccine technology.
• JS

  Jarad Schiffer, PhD

  Supervisory Health Scientist
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• TS

  Tino Schwarz, PhD

  Prof. Dr.
  Klinikum Wuerzburg Mitte, Standort Juliusspital
  Wuerzburg, Baden-Wurttemberg, Germany

  Disclosure: GSK group of companies: Scientific Research Study Investigator, Speaker's Bureau
• CB

  Carol Baker, MD

  Professor of Pediatrics
  University of Texas Health Science Center
  Houston, TX

  Disclosure: Nothing to disclose
• MD

  Michael Diamond, MD, PhD

  Herbert S. Gasser Professor
  Washington University
  St. Louis, MO

  Disclosure: Moderna: Advisor or Review Panel member, M.S.D. is a member of the Scientific Advisory Board for Moderna.
• LR

  Lars Rombo, MD, PhD

  Consultant
  Dept of Infectious Diseases, Uppsala University
  Eskilstuna, Sodermanlands Lan, Sweden

  Disclosure: Nothing to disclose
• KP

  Karlis Pauksens, MD

  Associate professor
  Dept of Infectious Diseases, Uppsala University
  Uppsala, Uppsala Lan, Sweden

  Disclosure: Nothing to disclose
• EB

  Estelle Berengier, MSc

  Laboratory study manager
  GSK
  Rixensart, Brabant Wallon, Belgium

  Disclosure: GSK group of companies: Employee
• CH

  Caroline Hervé, PhD

  Dr.
  GSK
  Wavre, Brabant Wallon, Belgium

  Disclosure: GSK group of companies: Employee
• LO

  Lidia Oostvogels, MD

  MD
  GSK
  Wavre, Brabant Wallon, Belgium

  Disclosure: GSK group of companies: Employee, Shareholder

Moderator(s)

• 

  Manisha Patel, MD MS

  Team Lead, Domestic Measles
  CDC
  Atlanta, GA

  Disclosure: Nothing to disclose
• CH

  C. Mary Healy, MD

  Associate Professor of Pediatrics
  Baylor College of Medicine
  Houston, TX

  Disclosure: National Foundation of Infectious Diseases: Honorarium for presentation, Other Financial or Material Support
  UP to Date: Author and Reviewer, Other Financial or Material Support

Presenting Author(s)

• SB

  Shalom Ben-Shimol, MD

  Senior Consultant PID
  Soroka University Med Ctr and Ben-Gurion University
  Beer Sheva, HaDarom, Israel

  Disclosure: Pfizer: Grant/Research Support, Speaker's Bureau
• PG

  Paul Gastanaduy, MD, MPH

  Medical Epidemiologist
  CDC
  Atlanta, GA

  Disclosure: Nothing to disclose
• CH

  C. Mary Healy, MD

  Associate Professor of Pediatrics
  Baylor College of Medicine
  Houston, TX

  Disclosure: National Foundation of Infectious Diseases: Honorarium for presentation, Other Financial or Material Support
  UP to Date: Author and Reviewer, Other Financial or Material Support
• BJ

  Brett Jagger, MD, PhD

  Infectious Diseases Fellow
  Washington University
  St. Louis, MO

  Disclosure: Nothing to disclose
• AS

  Anne Schuind, MD

  MD
  GSK
  Rockville, Maryland

  Disclosure: GSK group of companies: Employee, Shareholder